Zynerba Pharmaceuticals Announces Grant of New US Patent for
DEVON, Pa., Oct. 6, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticalsinc CYNEthe leading provider of innovative pharmaceutically manufactured transdermal cannabinoid therapies for rare neuropsychiatric disorders, announced